BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10357023)

  • 1. Platelet 5-HT and plasma MHPG levels in patients with bipolar I and bipolar II depressions and normal controls.
    Shiah IS; Ko HC; Lee JF; Lu RB
    J Affect Disord; 1999; 52(1-3):101-10. PubMed ID: 10357023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased platelet serotonin in bipolar depression and hypomania.
    Wirz-Justice A; Pühringer W
    J Neural Transm; 1978; 42(1):55-62. PubMed ID: 565391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of 3-methoxy-4-hydroxyphenylglycol in depressed patients compared with normal controls.
    Azorin JM; Raucoules D; Valli M; Levy C; Lancon C; Luccioni JM; Tissot R
    Neuropsychobiology; 1990; 23(1):18-24. PubMed ID: 2280827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma free 3-methoxy-4-hydroxyphenylglycol predicts response to fluoxetine.
    Ko HC; Lu RB; Shiah IS; Hwang CC
    Biol Psychiatry; 1997 Apr; 41(7):774-81. PubMed ID: 9084896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma MHPG in rapid cyclers and healthy twins.
    Jimerson DC; Nurnberger JI; Post RM; Gershon ES; Kopin IJ
    Arch Gen Psychiatry; 1981 Nov; 38(11):1287-90. PubMed ID: 7197905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noradrenergic responses to clonidine in acute and remitted depressed male patients.
    Trestman RL; Lawrence TL; Coccaro EF; Harvey P; Bernstein D; Lawrence EK; Condello V; Mahon T; Yang RK; Knott P
    Psychiatry Res; 1992 Sep; 43(3):199-213. PubMed ID: 1332095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comorbid depression and platelet serotonin in hemodialysis patients.
    Barisić I; Pivac N; Mück-Seler D; Jakovljević M; Sagud M
    Nephron Clin Pract; 2004; 96(1):c10-4. PubMed ID: 14752248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered 5-HT-induced calcium response in the presence of staurosporine in blood platelets from bipolar disorder patients.
    Suzuki K; Kusumi I; Akimoto T; Sasaki Y; Koyama T
    Neuropsychopharmacology; 2003 Jun; 28(6):1210-4. PubMed ID: 12700717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of circadian MHPG rhythmicity in major depression.
    Piletz JE; DeMet E; Gwirtsman HE; Halaris A
    Biol Psychiatry; 1994 Jun; 35(11):830-42. PubMed ID: 8054405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma 3-methoxy-4-hydroxyphenylglycol in manic patients: relationships with clinical variables.
    Azorin JM; Pupeschi G; Valli M; Joanny P; Raucoules D; Lancon C; Tissot R
    Acta Psychiatr Scand; 1990 Jan; 81(1):14-8. PubMed ID: 2330823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet membrane alpha 2-adrenergic receptors in depression.
    Karege F; Bovier P; Widmer J; Gaillard JM; Tissot R
    Psychiatry Res; 1992 Sep; 43(3):243-52. PubMed ID: 1359596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of electroconvulsive therapy on peripheral adrenoceptors, plasma, noradrenaline, MHPG and cortisol in depressed patients.
    Werstiuk ES; Coote M; Griffith L; Shannon H; Steiner M
    Br J Psychiatry; 1996 Dec; 169(6):758-65. PubMed ID: 8968635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced brain 5-HT and elevated NE turnover and metabolites in bipolar affective disorder.
    Young LT; Warsh JJ; Kish SJ; Shannak K; Hornykeiwicz O
    Biol Psychiatry; 1994 Jan; 35(2):121-7. PubMed ID: 7513191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High plasma serotonin levels in primary pulmonary hypertension. Effect of long-term epoprostenol (prostacyclin) therapy.
    Kéreveur A; Callebert J; Humbert M; Hervé P; Simonneau G; Launay JM; Drouet L
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2233-9. PubMed ID: 11031209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid biogenic amine metabolites, plasma-rich platelet serotonin and [3H]imipramine reuptake in the primary fibromyalgia syndrome.
    Legangneux E; Mora JJ; Spreux-Varoquaux O; Thorin I; Herrou M; Alvado G; Gomeni C
    Rheumatology (Oxford); 2001 Mar; 40(3):290-6. PubMed ID: 11285376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary 3-methoxy-4-hydroxyphenylglycol (MHPG) excretion in depression.
    Steiner M; Radwan M; Elizur A; Blum I; Atsmon A; Davidson S
    Jpn J Exp Med; 1979 Apr; 49(2):95-9. PubMed ID: 480680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The heterogeneity of 3-methoxy-4-hydroxyphenylglycol levels among depressed patients.
    Karege F; Bovier P; Gaillard JM; Tissot R
    Acta Psychiatr Scand; 1989 Nov; 80(5):499-504. PubMed ID: 2596350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin-induced platelet intracellular calcium mobilization in depressed patients.
    Kusumi I; Koyama T; Yamashita I
    Psychopharmacology (Berl); 1994 Jan; 113(3-4):322-7. PubMed ID: 7862840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tricyclic-induced mania and MHPG excretion.
    Zis AP; Cowdry RW; Wehr TA; Muscettola G; Goodwin FK
    Psychiatry Res; 1979 Jul; 1(1):93-9. PubMed ID: 298343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward a biochemical classification of depressive disorders. I. Differences in urinary excretion of MHPG and other catecholamine metabolites in clinically defined subtypes of depressions.
    Schildkraut JJ; Orsulak PJ; Schatzberg AF; Gudeman JE; Cole JO; Rohde WA; LaBrie RA
    Arch Gen Psychiatry; 1978 Dec; 35(12):1427-33. PubMed ID: 727878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.